Copertina

Can we prevent fatal liver failure under valproate?

Valproic acid (VPA) has been used as an anticonvulsant for more than 30 years. Meanwhile, VPA has also been approved by the FDA for the treatment of bipolar disorders. We report the case of a 58-year-old female patient, who died from liver failure, probably due to treatment with VPA.

Salvato in:
Dettagli Bibliografici
Autori principali: Schmid, Markus (Autore) , Connemann, B. J. (Autore) , Wolf, R. C. (Autore) , Flechtenmacher, Christa (Autore) , Eisenbach, Christoph (Autore) , Schönfeldt-Lecuona, C. (Autore)
Natura: Article (Journal) Editorial
Lingua:inglese
Pubblicazione: 25. Mai 2010
In: Pharmacopsychiatry
Year: 2010, Volume: 43, Fascicolo: 5, Pages: 198-200
ISSN:1439-0795
DOI:10.1055/s-0030-1254125
Accesso online:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0030-1254125
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0030-1254125
Testo
Note sull'autore:M.M. Schmid, B.J. Connemann, R.C. Wolf, C. Flechtenmacher, C. Eisenbach, C. Schönfeldt-Lecuona
Descrizione
Riassunto:Valproic acid (VPA) has been used as an anticonvulsant for more than 30 years. Meanwhile, VPA has also been approved by the FDA for the treatment of bipolar disorders. We report the case of a 58-year-old female patient, who died from liver failure, probably due to treatment with VPA.
Descrizione del documento:Gesehen am 13.06.2023
Descrizione fisica:Online Resource
ISSN:1439-0795
DOI:10.1055/s-0030-1254125

Documenti analoghi